1 n 101 (57%) cases and follicular mixed small cleaved-cell and large-cell in 76 (43%).

2 omas (FSCCs), 2 of 35 follicular mixed small cleaved-cell and large-cell lymphomas (FMxs), 1 of 4 fol

3 n in a classical pathway-mediated system and cleaved cell-bound C4b more efficiently than the C isofo

4 ubtypes: large-cell immunoblastic, small non-cleaved cell (Burkitt's or Burkitt's-like) and diffuse l

5 0 patients with high-grade, SNCCL (small non-cleaved cell, Burkitt's, and non-Burkitt's), who at pres

6               Histology was follicular small cleaved-cell in 101 (57%) cases and follicular mixed sma

7 xpressed on the surfaces of follicular small cleaved-cell lymphoma (FSCCL) cells, the in vivo effects

8 ocols for adults and children with small non-cleaved-cell lymphoma (SNCL) for many years and report h

9 erved between patients with follicular small cleaved-cell lymphoma and follicular mixed lymphoma, or

10 s, 65 had previously suffered from small non-cleaved-cell lymphoma, 16 from lymphoblastic lymphoma, a

11 ients had a prior diagnosis of diffuse small cleaved-cell lymphoma.

12 cell lymphomas (FLCs), 1 of 14 diffuse small cleaved-cell lymphomas (DSCCs), 2 of 17 diffuse mixed sm

13 c lymphomas (SLLs), 2 of 38 follicular small cleaved-cell lymphomas (FSCCs), 2 of 35 follicular mixed

14 ity, unrelated to small lymphocytic or small-cleaved-cell lymphomas.

15           In 22 of 27 (81%) follicular small cleaved cell non-Hodgkin's B-cell lymphomas, the CPP32-i

16  neuropathy (SAN) in patients with small non-cleaved-cell (SNCL) and large-cell lymphoma (LCL) treate

17 6F0 cells (GRP78(low)) have lower amounts of cleaved cell-surface GRP78.

18  to the WHO criteria, or as follicular large cleaved cell type (FLC).

19 es, respectively, whereas the residual small-cleaved cells were poorly stained for CPP32 in all FLCLs